ナットウキナーゼとスパイクタンパク質・心血管の健康に関する研究

We recently published a, a paper looking at all of the biological activities of nattokinase, and we found it does so many things in the post, post-COVID era.

Not only does in the laboratory it breaks down the spike protein itself. So in the test tube, nattokinase exposed to spike protein, which again comes from these injections as well, the nattokinase literally dissolves it.

Human study is now needed on that. It dissolves amyloid microclots in the test tube as well.

Amyloid microclots basically are spawned from the spike protein. This is misfolded, uh, fibrin that is basically collects in the body from spike protein exposure.

So it clears both of those. Again, in the laboratory, we need human testing. And then it also shrinks arterial plaque by thirty-six percent.

Wow. These are human randomized trials. So it clears up the clogged arteries.

And lastly, it decreases blood pressure by about three points, uh, significantly in human data and decreases cardiovascular death. So it increases causes of that, and it decreases stroke risk. Um, these, these are in large scale epidemiological studies.

And it helps clear normal blood clots, which also the COVID shots cause